What it is

KPV is the C-terminal tripeptide of α-melanocyte-stimulating hormone, studied in gut-inflammation and innate immune-signaling research. Preclinical work examines anti-inflammatory and barrier-related endpoints in intestinal and skin models.

Also known as

Lys-Pro-Val · α-MSH C-terminal tripeptide · KPV tripeptide

Overview

KPV is the C-terminal tripeptide of α-melanocyte-stimulating hormone, studied in gut-inflammation and innate immune-signaling research. Preclinical work examines anti-inflammatory and barrier-related endpoints in intestinal and skin models.

It also appears as a component of the KLOW blend for multi-peptide regenerative catalogs. Left Turn Adventures supplies this compound for laboratory and research use only.

Proven benefits

Note: Preclinical / literature endpoints for labs — not established human treatment benefits. Not a protocol.

• Gut-inflammation and mucosal endpoints in preclinical models

• • α-MSH–pathway immune-signaling markers

• • Skin and barrier inflammation readouts where studied

• • NF-κB–adjacent anti-inflammatory measures in literature

• • Comparative melanocortin-fragment pharmacology

Results timeline

Note: Illustrative research-observation windows — not a clinical schedule. No dosing.

Week 1–2: Early tissue and inflammation readouts in acute injury or repair models; compound exposure establishing.

Week 3–4: Clearer repair, angiogenesis, and mobility-adjacent markers in short research windows.

Month 2–3: More pronounced tendon/ligament/soft-tissue endpoints in extended preclinical designs.

Month 3–6: Sustained remodeling and recovery-marker observations where studied longer.

The catalog, not a clinic

For laboratory and research use only. Not for human or animal consumption. Products are sold solely to qualified researchers and licensed laboratories. No dosing or reconstitution on this page.